Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16307 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Zhenwei Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Central Hospital of Yongzhou, Yongzhou, Hunan Province, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Hysterectomy, Adenocarcinoma, Chemoradiotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
To compare oncological outcomes of radical hysterectomy (RH) and radiochemotherapy (R‐CT) for stage IIIC1 (FIGO 2018) cervical adenocarcinoma patients.
Methods
Based on the Chinese Cervical Cancer Clinical Diagnosis and Treatment Project Database, we retrospectively reviewed 236 cases of FIGO stage IIIC1 cervical adenocarcinoma diagnosed between 2005 and 2019. The 5‐year overall survival (OS) and 5‐year disease‐free survival (DFS) rates were compared between the two treatment groups using multivariate Cox regression models and the log‐rank test, both in the overall study population and after propensity score matching (PSM).
Results
From 63 926 patients, we selected 236 cases, including 203 in the RH group and 33 in the R‐CT group. In the overall study population, R‐CT was associated with significantly worse 5‐year OS (51.8% vs. 67.2%, p < 0.05) and 5‐year DFS (43.1% vs. 60.1%, p < 0.05) compared to RH. Multivariate analysis revealed that R‐CT was an independent risk factor for 5‐year DFS (hazard ratio [HR] = 2.226, 95% confidence interval [CI] 1.141–4.343, p < 0.05) but not for 5‐year OS (HR = 1.834, 95% CI: 0.829–4.061, p > 0.05) in FIGO stage IIIC1 cervical adenocarcinoma. After matching ( n = 26 in R‐CT group vs. 73 in RH group), the R‐CT group showed significantly lower 5‐year OS (50.3% vs. 77.4%, p < 0.05) and DFS (38.2% vs. 65.0%, p < 0.05) compared to the RH group. In the matched cohort, R‐CT remained an independent risk factor for 5‐year DFS (HR = 2.299, 95% CI: 1.113–4.750, p < 0.05) but not for 5‐year OS (HR = 1.926, 95% CI: 0.792–4.682, p > 0.05).
Conclusion
Among patients with stage FIGO 2018 IIIC1 cervical cancer adenocarcinoma, R‐CT was not associated with better oncological outcomes than RH. Radiotherapy should not be the only recommended treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The Central Hospital of Yongzhou, Yongzhou, Hunan Province, China.
- Department of Gynecology, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan Province, China.
- Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
- Department of Gynecology, Shanxi Cancer Hospital, Shanxi Medical University, TaiYuan, China.
ORCID-Profile: Chunlin Chen, Ping Liu
Zitieren
APA
Gao, Z., Yin, Z., Sun, L., Zhao, H., Chen, C., & Liu, P. (2025). Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16307
Vancouver
Gao Z, Yin Z, Sun L, Zhao H, Chen C, Liu P. Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16307
BibTeX
@article{Gao2025,
author = {Gao, Zhenwei and Yin, Zhaohong and Sun, Lixin and Zhao, Hongwei and Chen, Chunlin and Liu, Ping},
title = {Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16307}
}
EUVIMED